Rodgers K, Girgis W, diZerega G S, Johns D B
Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
Int J Fertil. 1990 Jan-Feb;35(1):40-5.
Previous studies showed that drugs that suppress prostaglandin synthesis were able to prevent adhesion formation following surgical trauma to the peritoneum. In our study, this premise was extended to examine the effects of various delivery systems on the ability of a nonsteriodal antiinflammatory drug, tolmetin, to prevent intraperitoneal adhesion formation after a standardized injury to the peritoneum. Continuous delivery of small amounts of tolmetin directly to the injury site following parietal peritoneal injury led to a significant reduction in the number and severity of adhesions formed. A single intraperitoneal injection of tolmetin in 5% Tween, however, required a relatively higher concentration of drugs to prevent adhesion formation. In a follow-up study of abrasion and devascularization of both uterine horns, the acid form of tolmetin was shown to be more potent than the sodium salt for the prevention of adhesion formation.
先前的研究表明,抑制前列腺素合成的药物能够防止腹膜手术创伤后粘连的形成。在我们的研究中,这一前提被扩展,以检验各种给药系统对非甾体抗炎药托美丁预防腹膜标准化损伤后腹腔粘连形成能力的影响。在壁腹膜损伤后将少量托美丁直接持续递送至损伤部位,导致形成的粘连数量和严重程度显著降低。然而,在5%吐温中单次腹腔注射托美丁需要相对较高的药物浓度来防止粘连形成。在一项对双侧子宫角擦伤和血管脱失的随访研究中,托美丁的酸形式在预防粘连形成方面比钠盐更有效。